Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Ketosis × eribulin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 40 Neoplasms 12 Neoplasm Metastasis 8 Sarcoma 6 Triple Negative Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Liposarcoma 2 Leiomyosarcoma 2 Inflammatory Breast Neoplasms 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasm, Residual 1 Metastatic Urothelial Cell Cancer 1 Lymphoma 1 Lung Neoplasms 1 Ketosis 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02061085 2025-06-08

MERIBEL

MedSIR

Phase 2 Completed

53 enrolled 11 charts

Breast Neoplasms, Ketosis, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡